BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30

• Drug Development

  Adherex Technologies Inc. Announces Global Development Plans For Advancing Eniluracil Into Phase III By Mid 2007

  November 16, 2005

   · 

  1 min read
• Drug Development

  Researchers To Present Positive Phase I Study Results For AmpliMed Corporation’s(TM) Amplimexon(R) (imexon inj.) In Patients With Advanced Solid Tumors

  November 16, 2005

   · 

  2 min read
• Drug Development

  Celera Genomics Presents Further Data From Its Histone Deacetylase Inhibitor Program As Cancer Therapeutics

  November 16, 2005

   · 

  1 min read
• Drug Development

  MethylGene Updates On Multi-Targeted Kinase Inhibitor Program, Discloses Additional Anti-Angiogenic Targets

  November 16, 2005

   · 

  1 min read
• Drug Development

  Biogen Idec, Inc. (California) Release: Positive Results Of Phase III Study Of Rituxan In Rheumatoid Arthritis To Be Presented At American College of Rheumatology Meeting

  November 16, 2005

   · 

  1 min read
• BioMidwest

  Samaritan Pharmaceuticals, Inc. Continues To Effectively Expand Valuable Patent Portfolio; Samaritan’s Drug Development Pipeline Consists Of 250 Possible Drug Candidates Based On Twenty-Six Patent Applications Worldwide

  November 16, 2005

   · 

  1 min read
• Drug Development

  Alnylam Pharmaceuticals Announces Progress In Pre-clinical Programs At The 35th Annual Society for Neuroscience Meeting; Pre-clinical Data From Parkinson’s Disease, Huntington’s Disease, And Neuropathic Pain Programs

  November 16, 2005

   · 

  1 min read
• Drug Development

  Ecopia BioSciences Inc. Presents Breast And Prostate Cancer Data At AACR-NCI-EORTC

  November 16, 2005

   · 

  1 min read
• Business

  MFIC Corporation Announces Appointment Of New Directors

  November 16, 2005

   · 

  1 min read
• Drug Development

  Dermisonics, Inc. Begins Next-Phase Clinical Trial Of Proprietary Insulin Patch Drug-Delivery System For $5.4 Billion Insulin Market; New Human Pilot Trial To Test For Skin Sensitivity Of Painless, Noninvasive U-Strip Insulin Patch

  November 16, 2005

   · 

  1 min read